Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nivolumab + Tacrolimus + Prednisone ± Ipilimumab for Kidney Transplant Recipients With Advanced Cutaneous Cancers
Kara M. Schenk, Julie S. Deutsch, Sunandana Chandra, et al.
Journal of Clinical Oncology (2024) Vol. 42, Iss. 9, pp. 1011-1020
Closed Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

Cemiplimab for Kidney Transplant Recipients With Advanced Cutaneous Squamous Cell Carcinoma
Glenn J. Hanna, Harita Dharanesswaran, Anita Giobbie‐Hurder, et al.
Journal of Clinical Oncology (2024) Vol. 42, Iss. 9, pp. 1021-1030
Open Access | Times Cited: 28
Clonal dynamics of alloreactive T cells in kidney allograft rejection after anti-PD-1 therapy
Garrett S. Dunlap, Daniel DiToro, Joel Henderson, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 18
Fine-tuning tumor- and allo-immunity: advances in the use of immune checkpoint inhibitors in kidney transplant recipients
Tess Van Meerhaeghe, Naoka Murakami, Alaín Le Moine, et al.
Clinical Kidney Journal (2024) Vol. 17, Iss. 4
Open Access | Times Cited: 7
Identifying Candidates for Immunotherapy among Patients with Non-Melanoma Skin Cancer: A Review of the Potential Predictors of Response
Enrico Zelin, Carlo Alberto Maronese, Arianna Dri, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 12, pp. 3364-3364
Open Access | Times Cited: 27
Immune suppression sustained allograft acceptance requires PD1 inhibition of CD8+ T cells
Hilary Miller‐Handley, Gavin Harper, Giang Pham, et al.
The Journal of Immunology (2025) Vol. 214, Iss. 1, pp. 192-198
Closed Access
Treatment of Merkel Cell Carcinoma in Organ Transplant Recipients - A Systematic Review
Darryl Chin Kai Xian, Choon Chiat Oh
JAAD International (2025) Vol. 19, pp. 75-82
Open Access
Treatment with programmed-death-1 inhibitors for non-melanoma skin cancer among immunocompromised patients with subgroup analysis of solid organ transplant patients
Eyal Yosefof, Nofar Edri, Idan Ben-Nachum, et al.
The Oncologist (2025) Vol. 30, Iss. 2
Open Access
Combined standard immunosuppression and immune checkpoint inhibition for BKPyV+ metastatic renal cell carcinoma of the graft in a kidney transplant recipient with chronic rejection: a case report
Ilaria Gandolfini, Martina Manini, Giuseppe Daniele Benigno, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Immune checkpoint inhibitors use in lung transplant recipients: a case series and systematic review of literature
N Mahmoud, G. Pamart, Charlée Nardin, et al.
ESMO Open (2025) Vol. 10, Iss. 4, pp. 104537-104537
Open Access
Successful use of cemiplimab in a high immunologic risk kidney transplant recipient with metastatic squamous cell carcinoma
Elena-Bianca Barbir, Abdullah Jalal, Joseph P. Grande, et al.
Transplant Immunology (2025), pp. 102242-102242
Closed Access
An Updated Review of Immune Checkpoint Inhibitors in Cutaneous Oncology: Beyond Melanoma
James P. Pham, Ramon Staeger, Anthony M. Joshua, et al.
European Journal of Cancer (2024) Vol. 214, pp. 115121-115121
Open Access | Times Cited: 3
Liver transplant patient with in-transit squamous cell carcinoma treated with talimogene laherparepvec
Jamie Lebhar, Jennifer Jacobs, Khushnood Faraz, et al.
JAAD Case Reports (2023) Vol. 40, pp. 53-57
Open Access | Times Cited: 4
Use of immune checkpoint inhibitors in solid organ transplant recipients with advanced cutaneous malignancies
Stephanie Ji, Hao Liu, Laura A. Pachella, et al.
Frontiers in Transplantation (2023) Vol. 2
Open Access | Times Cited: 4
Systemic Therapy for Non-Melanoma Skin Cancers: Latest Advances
Spencer Lessans, Katie A. O’Connell, Jennifer H. Choe
Current Oncology Reports (2024) Vol. 26, Iss. 9, pp. 1120-1133
Open Access | Times Cited: 1
Current Advances and Challenges in the Management of Cutaneous Squamous Cell Carcinoma in Immunosuppressed Patients
Sophie H. Li, Thomas Townes, Shorook Na’ara
Cancers (2024) Vol. 16, Iss. 18, pp. 3118-3118
Open Access | Times Cited: 1
Diagnosis and Management of Immune Checkpoint Inhibitor-Associated Nephrotoxicity: A Position Statement from the American Society of Onco-nephrology
Sandra M. Herrmann, Ala Abudayyeh, Shruti Gupta, et al.
Kidney International (2024)
Closed Access | Times Cited: 1
Solid Organ Transplantation Is Associated with an Increased Rate of Mismatch Repair Deficiency and PIK3CA Mutations in Colorectal Cancer
Eric S. Christenson, Valerie Lee, Hao Wang, et al.
Current Oncology (2022) Vol. 30, Iss. 1, pp. 75-84
Open Access | Times Cited: 3
Checkpoint Inhibition for Kidney Transplant Recipients With Advanced Cutaneous Carcinomas: An Emerging Standard for Select Patients
Shlomo A. Koyfman, J.L. Geiger
Journal of Clinical Oncology (2024) Vol. 42, Iss. 9, pp. 981-983
Closed Access
Multiple Options: How to Choose Therapy in Frontline Metastatic Melanoma
Lucy Boyce Kennedy, April K.S. Salama
Current Oncology Reports (2024)
Closed Access
Immunotherapy for Advanced Skin Cancer in Kidney Transplant Recipients—The High-Risk Balancing Act
Madeliene Stump, Sarah T. Arron, Charlotte M. Proby
JAMA Dermatology (2024) Vol. 160, Iss. 8, pp. 799-799
Closed Access
Cutaneous Squamous Cell Carcinoma in Patients with Solid-Organ-Transplant-Associated Immunosuppression
Karam Khaddour, Naoka Murakami, Emily S. Ruiz, et al.
Cancers (2024) Vol. 16, Iss. 17, pp. 3083-3083
Open Access
Treatment of skin cancers in solid organ transplant recipients: current status and future perspectives
E. Ducroux, Jean Kanitakis
Expert Review of Anticancer Therapy (2024)
Closed Access
Immune Checkpoint Inhibitor Therapy for Kidney Transplant Recipients – A Review of Potential Complications and Management Strategies
Elena Bianca Barbir, Samer Abdulmoneim, Arkadiusz Z. Dudek, et al.
Transplant International (2024) Vol. 37
Open Access
Cancer Screening and Cancer Treatment in Kidney Transplant Recipients
Miguel Bigotte Vieira, Hiroyuki Arai, Carla Nicolau, et al.
Kidney360 (2024) Vol. 5, Iss. 10, pp. 1569-1583
Open Access
Immunotherapy in the era of transplant oncology: Risks and complications
Bilal Anouti, Reham Abdel‐Wahab, Adi Diab
Elsevier eBooks (2024), pp. 135-147
Closed Access
Page 1 - Next Page

Scroll to top